These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7847131)

  • 1. Prevention of delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA). A prospective study.
    Seifert V; Stolke D; Zimmermann M; Feldges A
    Acta Neurochir (Wien); 1994; 128(1-4):137-43. PubMed ID: 7847131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study.
    Stolke D; Seifert V
    Neurosurgery; 1992 Jun; 30(6):877-81. PubMed ID: 1614590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Sasaki T; Ohta T; Kikuchi H; Takakura K; Usui M; Ohnishi H; Kondo A; Tanabe H; Nakamura J; Yamada K
    Neurosurgery; 1994 Oct; 35(4):597-604; discussion 604-5. PubMed ID: 7808602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of alteplase in prevention of cerebral vasospasm and its sequelae in patients after aneurysmal subarachnoid hemorrhage from ruptured cerebral aneurysm].
    Majchrzak H; Lech A; Kopera M; Gajos L; Dragan T; Ladziński P
    Neurol Neurochir Pol; 1995; 29(3):379-87. PubMed ID: 7566413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal fibrinolysis using recombinant tissue plasminogen activator (rTPA) for prevention of cerebral vasospasm and delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage. Experimental and clinical data.
    Seifert V
    Neurol Res; 1994 Feb; 16(1):54-8. PubMed ID: 7913533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of intraoperative using of recombinant tissue plasminogen activator on the development of cerebral angiospasm after subarachnoid haemorrhage in patients with ruptured intracranial aneurysms.
    Górski R; Zabek M; Jarmuzek P
    Neurol Neurochir Pol; 2000; 34(6 Suppl):41-7. PubMed ID: 11452854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
    Sasaki T; Ohta T; Kikuch H; Takakura K; Usui M; Kondoh A; Tanabe H; Nakamura J; Yamada K
    No To Shinkei; 1992 Nov; 44(11):1001-8. PubMed ID: 1296711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.
    Usui M; Saito N; Hoya K; Todo T
    Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Ohman J; Servo A; Heiskanen O
    J Neurosurg; 1991 Aug; 75(2):197-201. PubMed ID: 1906535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB
    J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: preliminary report.
    Mizoi K; Yoshimoto T; Fujiwara S; Sugawara T; Takahashi A; Koshu K
    Neurosurgery; 1991 Jun; 28(6):807-12; discussion 812-3. PubMed ID: 1906142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator.
    Mizoi K; Yoshimoto T; Takahashi A; Fujiwara S; Koshu K; Sugawara T
    J Neurosurg; 1993 Mar; 78(3):430-7. PubMed ID: 8433145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage.
    Shibuya M; Suzuki Y; Enomoto H; Okada T; Ogura K; Sugita K
    Acta Neurochir (Wien); 1994; 131(1-2):19-25. PubMed ID: 7709781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage.
    Steinberg GK; Vanefsky MA; Marks MP; Adler JR; Koenig GH
    Neurosurgery; 1994 May; 34(5):809-13; discussion 813-4. PubMed ID: 8052377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
    Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
    J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome from poor grade aneurysmal subarachnoid haemorrhage--which poor grade subarachnoid haemorrhage patients benefit from aneurysm clipping?
    Hutchinson PJ; Power DM; Tripathi P; Kirkpatrick PJ
    Br J Neurosurg; 2000 Apr; 14(2):105-9. PubMed ID: 10889881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage.
    Seifert V; Eisert WG; Stolke D; Goetz C
    Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amount of subarachnoid blood and vasospasm: current aspects. A transcranial Doppler study.
    Schaller C; Rohde V; Meyer B; Hassler W
    Acta Neurochir (Wien); 1995; 136(1-2):67-71. PubMed ID: 8748829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases.
    Murayama Y; Malisch T; Guglielmi G; Mawad ME; Viñuela F; Duckwiler GR; Gobin YP; Klucznick RP; Martin NA; Frazee J
    J Neurosurg; 1997 Dec; 87(6):830-5. PubMed ID: 9384391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.